Bill Commons

HI SB 1509

died on adjournment

RELATING TO PRESCRIPTION DRUGS.

Hawaii · 2026 Regular Session · upper

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did HI SB 1509 pass?

No. HI SB 1509 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2025-12-08): Carried over to 2026 Regular Session.

What is HI SB 1509 about?

Requires the Legislative Reference Bureau to conduct a study on best practices for the regulation of pharmacy benefit managers and reduction in prescription drug costs for health insurance plan beneficiaries. Requires a report to the Legislature. Effective 12/31/2050. (HD1)

Who sponsors HI SB 1509?

KOUCHI is the primary sponsor of HI SB 1509.

Description

Requires the Legislative Reference Bureau to conduct a study on best practices for the regulation of pharmacy benefit managers and reduction in prescription drug costs for health insurance plan beneficiaries. Requires a report to the Legislature. Effective 12/31/2050. (HD1)

Introduced
2025-01-23
Latest action
2025-12-08 — Carried over to 2026 Regular Session.
Bill type
bill
Last updated
—

Subjects

Sponsors

  • KOUCHIprimary

Committees

Not provided by source.

Action timeline

Newest first

  1. 2025-12-08

    Carried over to 2026 Regular Session.

    carried-over

  2. 2025-03-19

    The committee(s) on CPC recommend(s) that the measure be deferred.

    deferral

  3. 2025-03-14

    Reported from HLT (Stand. Com. Rep. No. 1233) as amended in HD 1, recommending passage on Second Reading and referral to CPC.

  4. 2025-03-14

    Passed Second Reading as amended in HD 1 and referred to the committee(s) on CPC with none voting aye with reservations; none voting no (0) and Representative(s) Cochran, Holt, Iwamoto, Ward excused (4).

    reading-2,referral-committee

  5. 2025-03-14

    Bill scheduled to be heard by CPC on Wednesday, 03-19-25 2:00PM in House conference room 329 VIA VIDEOCONFERENCE.

  6. 2025-03-12

    The committee on HLT recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 8 Ayes: Representative(s) Takayama, Keohokapu-Lee Loy, Amato, Chun, Marten, Olds, Takenouchi; Ayes with reservations: Representative(s) Garcia; Noes: none; and 1 Excused: Representative(s) Alcos.

    committee-passage-favorable

  7. 2025-03-07

    Bill scheduled to be heard by HLT on Wednesday, 03-12-25 9:00AM in House conference room 329 VIA VIDEOCONFERENCE.

  8. 2025-03-06

    Pass First Reading

    reading-1

  9. 2025-03-06

    Referred to HLT, CPC, FIN, referral sheet 19

    referral-committee

  10. 2025-03-04

    Passed Third Reading, as amended (SD 1). Ayes, 25; Aye(s) with reservations: none . Noes, 0 (none). Excused, 0 (none). Transmitted to House.

    passage

  11. 2025-03-04

    Received from Senate (Sen. Com. No. 360) in amended form (SD 1).

    introduction,receipt

  12. 2025-02-28

    Reported from HHS/CPN (Stand. Com. Rep. No. 805) with recommendation of passage on Second Reading, as amended (SD 1) and placement on the calendar for Third Reading.

  13. 2025-02-28

    Report adopted; Passed Second Reading, as amended (SD 1).

    passage,reading-2,referral-committee

  14. 2025-02-28

    48 Hrs. Notice 03-04-25.

  15. 2025-02-24

    The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 4 Aye(s): Senator(s) San Buenaventura, Aquino, Hashimoto, Keohokalole; Aye(s) with reservations: none ; 0 No(es): none; and 1 Excused: Senator(s) Fevella.

    committee-passage-favorable

  16. 2025-02-24

    The committee(s) on CPN recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in CPN were as follows: 3 Aye(s): Senator(s) Keohokalole, McKelvey, Awa; Aye(s) with reservations: none ; 0 No(es): none; and 2 Excused: Senator(s) Fukunaga, Richards.

    committee-passage-favorable

  17. 2025-02-20

    The committee(s) on HHS/CPN has scheduled a public hearing on 02-24-25 1:00PM; Conference Room 225 & Videoconference.

  18. 2025-02-13

    Re-Referred to HHS/CPN.

    referral-committee

  19. 2025-01-27

    Referred to HHS, CPN.

    referral-committee

  20. 2025-01-23

    Introduced and passed First Reading.

    introduction,reading-1

  21. 2025-01-22

    Pending Introduction.

Versions

Documents

Votes

  • The committee(s) on CPN recommend(s) that the measure be PASSED, WITH AMENDMENTS.

    2025-02-24 · pass · 3-0

    Member-level votes (5)
    • Keohokalole: yes
    • McKelvey: yes
    • Awa: yes
    • Fukunaga: not voting
    • Richards: not voting
  • The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS.

    2025-02-24 · pass · 4-0

    Member-level votes (5)
    • San Buenaventura: yes
    • Aquino: yes
    • Hashimoto: yes
    • Keohokalole: yes
    • Fevella: not voting
  • Passed Third Reading, as amended (SD 1).

    2025-03-04 · pass · 25-0

  • The committee on HLT recommend that the measure be PASSED, WITH AMENDMENTS.

    2025-03-12 · pass · 8-0

    Member-level votes (9)
    • Takayama: yes
    • Keohokapu-Lee Loy: yes
    • Amato: yes
    • Chun: yes
    • Marten: yes
    • Olds: yes
    • Takenouchi: yes
    • Garcia: yes
    • Alcos: not voting

Related bills

No related bills recorded for this bill.

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:20:09.051962Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=HI&identifier=SB 1509. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.